BWA insider sold 7,500 shares in August; 2,690 shares slated for 08/28/2025 sale
Rhea-AI Filing Summary
BorgWarner Inc. insider sale notice (Form 144) — This filing reports that an individual received 2,690 shares on 02/05/2025 from a performance stock lapse as equity compensation and intends to sell those 2,690 common shares on 08/28/2025 through Charles Schwab & Co., Inc. at an aggregate market value of $115,470 on the NYSE. The filing also discloses that the same person sold 5,000 shares on 08/04/2025 for $188,550 and 2,500 shares on 08/12/2025 for $100,025. The filer certifies no undisclosed material adverse information.
Positive
- Performance award vested: 2,690 shares received on 02/05/2025 as equity compensation, indicating compensation alignment with company equity.
- Disclosure compliance: Filing provides required transparency of intended and recent insider sales through Rule 144.
Negative
- Insider sales disclosed: 7,500 shares sold in August 2025 for aggregate gross proceeds of $288,575, which may attract investor attention.
- Planned resale: Intended sale of 2,690 shares on 08/28/2025 with an aggregate market value of $115,470.
Insights
TL;DR: Routine insider sales and a scheduled sale of recently vested performance shares; no undisclosed material information stated.
The Form 144 documents an insider who received 2,690 shares via performance stock lapse on 02/05/2025 and plans a sale on 08/28/2025 through Charles Schwab. The filing also records two recent open-market dispositions totaling 7,500 shares with gross proceeds of $288,575. This is a disclosure of intended and recent sales required under Rule 144 and includes the standard representation that the seller is not aware of undisclosed material adverse information.
TL;DR: Transaction sizes are small relative to total outstanding shares; informational for trading transparency, limited market impact.
The notice shows the securities to be sold represent 2,690 shares versus 216,392,876 shares outstanding as listed in the form, and prior sales in August totaled 7,500 shares. The filing therefore meets Rule 144 disclosure requirements. No earnings or operational details are provided, so material valuation implications cannot be drawn from this form alone.